Hormonal contraception in overweight or obese women
237 results
1 - 100
Hormonal contraceptives for contraception in overweight or obese women
Hormonal contraception in overweight or obese women - Steroid hormones for contraception in women with sickle cell disease
- Hormonal versus non‐hormonal contraceptives in women with diabetes mellitus type 1 and 2
- Hormonal contraception for women at risk of HIV infection
- Hormonal and intrauterine methods for contraception for women aged 25 years and younger
- Hormonal contraception for women exposed to HIV infection: Cochrane systematic review
- Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2
Women who use levonorgestrel-releasing intrauterine devices are less likely to develop ischemic stroke than nonusers of hormonal contraception- Overweight in pregnancy
- Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus
- Contraception in patients with systemic diseases
- Risk of ischaemic stroke in persons with migraine without aura using combined hormonal contraception
- Abnormal menstrual bleeding
- Levonorgestrel is ineffective emergency contraception for obese women
- Certain hormonal contraceptives increase thromboembolism risk when taken with NSAIDs
- Contraception: initiation, choice of method and follow-up
- Breast cancer and hormonal contraceptives
- Copper containing intra‐uterine devices versus depot progestogens for contraception
- Risk of thromboembolism in patients with COVID‐19 who are using hormonal contraception
- Steroidal contraceptives: effect on bone fractures in women
- Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke
- Hormonal contraceptive use and depression
- Strategies to improve adherence and continuation of shorter‐term hormonal methods of contraception
- Immediate start of hormonal contraceptives for contraception
- Fertility returns within 6 months for more than 50% of the women who stop using contraceptives
- Combined hormonal contraceptives for heavy menstrual bleeding
- Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception
- Subdermal implants for contraception
- Hormonal contraception
- Steroidal contraceptives and bone fractures in women: evidence from observational studies
- High continuation of contraceptive ring vs patch
- Combination injectable contraceptives for contraception
- 20 mcg versus over 20 mcg estrogen combined oral contraceptives for contraception
- Combined hormonal versus non-hormonal versus progestin-only contraception in lactation
- Combined hormonal versus nonhormonal versus progestin‐only contraception in lactation
- Continuous or extended cycle use of combined oral contraceptives
- Oral contraceptives increase risk of thrombotic stroke and MI
- Progestin‐only contraceptives: effects on weight
- Risk of ischaemic stroke in people with migraine with aura
- Oral contraceptives in the treatment of endometriosis
- Repeated use of pre‐ and postcoital hormonal contraception for prevention of pregnancy
- Risk of venous thrombosis in users of 3rd vs. 2nd generation combined oral contraceptives
- Steroid hormones for contraception in men
- Progestogen‐releasing intrauterine systems versus other forms of reversible contraceptives for contraception
- Combined oral contraceptives for heavy menstrual bleeding
- Levonorgestrel intrauterine system vs. other forms of reversible contraceptives
- Combination contraceptives: effects on weight
- Combined oral contraceptives and bone mineral density
- Risk of venous thromboembolism in users of combined contraceptives
- Acne
- Biphasic versus triphasic oral contraceptives for contraception
- Bariatric surgery (obesity surgery)
- Depot medroxyprogesterone versus Norethisterone oenanthate for long‐acting progestogenic contraception.
- Oral contraceptives in women with systemic lupus erythematosus